Neurocrine Biosciences Inc. (NBIX)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

12780 EL CAMINO REAL SAN DIEGO, CA 92130

Neurocrine Biosciences Inc discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. The company's lead clinical development program, indiplon, is a drug for the treatment of insomnia.

Data based on most recent fiscal year report
Market Cap6.834 Billion Shares Outstanding88.49 Million Avg Volume1.648 Million
1-Yr BETA vs S&P TR1.173 Current Ratio10.2 Quick Ratio10.2
View SEC Filings from NBIX instead.
Q4 2018 All Institutions Hedge Funds 1
To trade NBIX now:
Filers who had this stock in their top 10: 9 6 (0.6%)
13F Filers holding this stock: 314 55 (5.5%)
Aggregate 13F shares on 12/31/2018: 89.522 Million 13.288 Million
Aggregate 13F shares on 09/30/2018: 87.812 Million 13.14 Million
Percent change: 1.95% 1.13%
Funds creating new positions: 69 14
Funds Adding to an existing position: 107 19
Funds closing out their position: 86 18
Funds reducing their position: 110 18
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NBIX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

31.2 Thousand total shares from 27 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SANDROCK ALFRED EVP, CHIEF MEDICAL OFFICER

  • Officer
8,753 2019-02-12 1

ABERNETHY MATT CHIEF FINANCIAL OFFICER

  • Officer
0 2019-02-07 2

ROBERTS EIRY CHIEF MEDICAL OFFICER

  • Officer
0 2019-02-07 2

GORMAN KEVIN CHARLES CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
417,597 2019-02-06 4

BOZIGIAN HAIG P. CHIEF DEVELOPMENT OFFICER

  • Officer
141,639 2019-02-06 5

GRIGORIADIS DIMITRI E. CHIEF RESEARCH OFFICER

  • Officer
120,065 2019-02-06 6

GANO KYLE CHIEF BUSINESS DEVELOPMENT OFF

  • Officer
85,833 2019-02-06 4

LLOYD-SMITH MALCOLM CHIEF REGULATORY OFFICER

  • Officer
19,238 2019-02-06 3

LIPPOLDT DARIN CHIEF LEGAL OFFICER

  • Officer
19,646 2019-02-06 3

BENEVICH ERIC CHIEF COMMERCIAL OFFICER

  • Officer
20,745 2019-02-06 3

NEVINNY CORINNE H

  • Director
0 2019-01-25 3

POPS RICHARD F

  • Director
32,500 2019-01-25 5

RASTETTER WILLIAM H

  • Director
79,672 2018-11-12 1

LYONS GARY A

  • Director
245,697 2018-11-02 4

SHERWIN STEPHEN A

  • Director
5,164 2018-10-31 3

ROBERTS BRYAN E

  • Director
  • 10% Owner
5,332,377 2018-06-20 0

MORROW GEORGE J

  • Director
0 2018-05-24 1

COUGHLIN TIMOTHY P

  • Director
0 2018-05-15 0

HOVE ANDERS D

  • Director
0 2018-03-01 0

OBRIEN CHRISTOPHER FLINT FORMER CHIEF MEDICAL OFFICER

  • Officer
55,946 2018-02-05 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

LAMPERT MARK N

  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
No longer subject to file 2017-07-14 0

MOLLICA JOSEPH A

  • Director
0 2017-05-22 0

GROS DAVID-ALEXANDRE C PRESIDENT & COO

  • Officer
0 2017-02-06 0

VALEUR JENSEN MARGARET E GENERAL COUNSEL

  • Officer
100,000 2016-02-01 0

MITCHELL W THOMAS

  • Director
1,000 2015-06-23 0

NEUROCRINE BIOSCIENCES INC

  • Director
16,030 2015-04-07 0

VALE WYLIE W

  • Director
0 2011-05-25 0

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP MANAGEMENT, LLC

HOVE ANDERS D

ROBERTS BRYAN E

  • 10% Owner
5,114,934 2011-02-02 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

  • 10% Owner
  • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
25,254,628 2009-06-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2019-02-07 A 15,423 a 15,423 20,745.00 direct

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2019-02-07 A 24,677 a 24,677 417,597.00 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2019-02-07 A 7,712 a 7,712 19,238.00 direct

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2019-02-07 A 62,506 a 62,506 19,646.00 direct

ROBERTS EIRY - Officer CHIEF MEDICAL OFFICER

2019-02-07 A 12,339 a 12,339 0.00 direct

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2019-02-07 A 9,254 a 9,254 120,065.00 direct

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2019-02-07 A 12,339 a 12,339 85,833.00 direct

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2019-02-07 A 83,341 a 83,341 20,745.00 direct

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2019-02-07 A 133,345 a 133,345 417,597.00 direct

ABERNETHY MATT - Officer CHIEF FINANCIAL OFFICER

2019-02-07 A 15,423 a 15,423 0.00 direct

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2019-02-07 A 41,671 a 41,671 19,238.00 direct

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2019-02-07 A 12,339 a 12,339 141,639.00 direct

ROBERTS EIRY - Officer CHIEF MEDICAL OFFICER

2019-02-07 A 66,673 a 66,673 0.00 direct

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2019-02-07 A 50,005 a 50,005 120,065.00 direct

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2019-02-07 A 66,673 a 66,673 85,833.00 direct

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2019-02-07 A 11,567 a 11,567 19,646.00 direct

ABERNETHY MATT - Officer CHIEF FINANCIAL OFFICER

2019-02-07 A 83,341 a 83,341 0.00 direct

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2019-02-07 A 66,673 a 66,673 141,639.00 direct

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2019-02-06 S 531 $84.03 d 120,065 120,065.00 direct yes

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2019-02-06 S 762 $83.56 d 85,833 85,833.00 direct yes

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2019-02-06 S 920 $83.54 d 141,639 141,639.00 direct yes

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2019-02-06 S 791 $83.52 d 19,646 19,646.00 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2019-02-06 S 920 $83.57 d 20,745 20,745.00 direct yes

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2019-02-06 S 4,096 $84.23 d 417,597 417,597.00 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2019-02-06 S 920 $83.58 d 19,238 19,238.00 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2019-02-05 S 603 $88.13 d 17,508 17,508.00 direct yes

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2019-02-05 S 669 $88.17 d 118,322 119,071.00 direct yes

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2019-02-05 S 465 $88.06 d 138,244 139,909.00 direct yes

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2019-02-05 S 470 $88.11 d 18,162 18,162.00 direct yes

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2019-02-05 S 1,300 $88.14 d 83,439 84,695.00 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2019-02-05 S 602 $88.08 d 17,595 19,015.00 direct yes

LLOYD-SMITH MALCOLM - Officer CHIEF REGULATORY OFFICER

2019-02-05 S 669 $88.16 d 16,574 17,508.00 direct yes

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2019-02-05 S 1,992 $88.28 d 413,943 413,943.00 direct yes

LIPPOLDT DARIN - Officer CHIEF LEGAL OFFICER

2019-02-05 S 755 $88.08 d 17,482 18,162.00 direct yes

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2019-02-05 S 465 $88.05 d 80,989 84,695.00 direct yes

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2019-02-05 S 401 $88.17 d 119,071 119,071.00 direct yes

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2019-02-05 S 885 $88.18 d 139,909 139,909.00 direct yes

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2019-02-05 S 669 $88.14 d 84,695 84,695.00 direct yes

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2019-02-05 S 2,497 $88.12 d 410,185 413,943.00 direct yes

BENEVICH ERIC - Officer CHIEF COMMERCIAL OFFICER

2019-02-05 S 755 $87.95 d 19,015 19,015.00 direct yes

GANO KYLE - Officer CHIEF BUSINESS DEVELOPMENT OFF

2019-02-04 S 1,375 $88.14 d 80,117 84,695.00 direct yes

GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER

2019-02-04 S 3,125 $88.10 d 408,082 413,943.00 direct yes

GRIGORIADIS DIMITRI E. - Officer CHIEF RESEARCH OFFICER

2019-02-04 S 1,375 $88.12 d 117,066 119,071.00 direct yes

BOZIGIAN HAIG P. - Officer CHIEF DEVELOPMENT OFFICER

2019-02-04 S 1,375 $88.10 d 137,372 139,909.00 direct yes

ROBERTS EIRY - Officer CHIEF MEDICAL OFFICER

2019-01-08 S 1,857 $84.09 d 3,143 3,143.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments